Sales decline 21.96% to Rs 40.48 crore
Net Loss of Parenteral Drugs (India) reported to Rs 9.28 crore in the quarter ended March 2014 as against net loss of Rs 17.91 crore during the previous quarter ended March 2013. Sales declined 21.96% to Rs 40.48 crore in the quarter ended March 2014 as against Rs 51.87 crore during the previous quarter ended March 2013.For the full year,net loss reported to Rs 58.70 crore in the year ended March 2014 as against net loss of Rs 85.20 crore during the previous year ended March 2013. Sales declined 0.38% to Rs 186.51 crore in the year ended March 2014 as against Rs 187.22 crore during the previous year ended March 2013.
ParticularsQuarter EndedYear EndedMar. 2014Mar. 2013% Var.Mar. 2014Mar. 2013% Var.Sales40.4851.87 -22 186.51187.22 0 OPM %-55.39-8.10 --8.94-11.83 - PBDT-36.40-11.47 -217 -70.92-64.36 -10 PBT-40.95-15.91 -157 -88.62-81.70 -8 NP-9.28-17.91 48 -58.70-85.20 31
Powered by Capital Market - Live News
